Melanocortin agonist for sexual desire and arousal — men and women.
PT-141 (bremelanotide) is a melanocortin-receptor agonist that acts centrally on desire and arousal. Unlike PDE5 inhibitors, it works through the CNS rather than vascular pathways.
Subcutaneous injection 45–60 minutes prior to intimacy; effect lasts 6–24 hours.
Agonist of MC3R/MC4R receptors in the CNS, modulating desire circuits.
Can cause transient nausea, flushing and blood-pressure elevation. Discuss with physician if cardiovascular disease.
This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.
PT-141 acts on desire in the brain; PDE5s act on vascular response.
Sometimes yes — under physician supervision.
45–60 minutes.
Blood pressure recommended early in therapy.
GHRH analog that stimulates your body's own growth hormone in a physiologic pattern.
Long-acting GHRH analog often paired with Ipamorelin for GH optimization.
Selective GH secretagogue with minimal impact on cortisol, prolactin or appetite.
Miami Beach clinic
1370 Washington Ave, Suite 227, Miami Beach, FL 33139
Hours
Mon–Fri 10am–6pm · Sat–Sun 10am–3pm
Service area
South Florida, including mobile IV therapy where appropriate.
Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.
